Indivior Pharmaceuticals Inc (INDV)
EBITDA Growth
101.22%
Quarterly · Period ending:
INDV EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported101.22%period ending
Latest reported101.22%period ending
INDV Quarterly EBITDA YoY % (-586.00% → 101.22%)
Year-over-year change
High-resolution chart · PNG
INDV ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 101.2195% | |
| 65.7895% | |
| -13.2075% | |
| 217.6471% | |
| 177.3585% | |
| -12.6437% | |
| 34.1772% | |
| 110.3659% | |
| -235.8974% | |
| 17.5676% | |
| 132.5103% | |
| -341.1765% | |
| 9.8592% | |
| 27.5862% | |
| -586% |